Acquisition Synergy The company was acquired by Cato SMS in September 2020, creating a path to integrate Array's biostatistics and programming capabilities with Cato's broader clinical research solutions. For business development, target joint opportunities with Cato's existing sponsor base, offering bundled statistics, programming and CRO services for mid-to-late phase trials.

Cloud Based Ops Array's stack includes AWS, Route 53 and Box, indicating strong cloud-native data handling and secure document management. Position as a cloud-ready partner for sponsors demanding scalable analytics, remote collaboration, and compliant data workflows across global trials.

Expert Biostatistics With a team of highly experienced biostatisticians and statistical programmers, Array offers high-touch, customized analysis and programming for complex study designs. Use this to pursue mid-market and niche-phase opportunities requiring advanced statistical methods, adaptive designs or bespoke programming.

Channel Partnerships The combination with Cato SMS and the existing CRO landscape create a fertile ground for channel partnerships, referrals, and co-selling opportunities. Develop joint go-to-market programs, cross-sell across the Cato network, and target sponsors seeking integrated CRO solutions.

Flexible Niche Services As a smaller, specialized CRO, Array can win sponsors who prioritize speed, flexibility and personalized service over scale. Position for mid-sized biotech and pharma clients needing rapid iterations, tailored analytics, and responsive support that larger CROs may not provide.